Universal Health Services (UHS) Reports Q2 Earnings: What Key Metrics Have to Say

Universal Health Services (UHS) reported $4.64 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 8.3%. EPS of $5.98 for the same period compares to $5.35 a year ago.

The reported revenue represents a surprise of +2.62% over the Zacks Consensus Estimate of $4.52 billion. With the consensus EPS estimate being $5.66, the EPS surprise was +5.65%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Universal Health Services performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Admissions - Acute - Same facility basis: 88,562 versus 86,913 estimated by two analysts on average.
• Admissions - Behavioral health: 116,857 versus 122,248 estimated by two analysts on average.
• Net Revenues- Behavioral health services: $2.03 billion versus the four-analyst average estimate of $1.98 billion. The reported number represents a year-over-year change of +7.7%.
• Net Revenues- Acute care hospital services: $2.61 billion versus the four-analyst average estimate of $2.55 billion. The reported number represents a year-over-year change of +8.7%.
• Operating Income- All Behavioral Health Care Services: $411.13 million versus $392.94 million estimated by three analysts on average.
• Operating Income- All Acute Care Hospital Services: $227.97 million versus $264.64 million estimated by three analysts on average.

View all Key Company Metrics for Universal Health Services here>>>

Shares of Universal Health Services have returned +6.9% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research